GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales GrowthZacks Investment Research • 04/29/26
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policiesCNBC • 04/29/26
GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBioProactive Investors • 04/27/26
GSK sees blockbuster potential in targeted cancer therapy after promising early dataReuters • 04/12/26
GSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug's label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.WSJ • 04/09/26
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, MarylandPRNewsWire • 03/31/26
Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.Barrons • 03/30/26
GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit TranscriptSeeking Alpha • 03/26/26
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung CancerZacks Investment Research • 03/23/26